Literature DB >> 22241893

Managing microvascular complications of diabetes with microRNAs.

Shawn S Badal, Farhad R Danesh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22241893      PMCID： PMC3269171          DOI： 10.1681/ASN.2011121222

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  17 in total

1.  Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.

Authors:  Jianyin Long; Yin Wang; Wenjian Wang; Benny H J Chang; Farhad R Danesh
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

2.  Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.

Authors:  Christoph Roderburg; Gerd-Willem Urban; Kira Bettermann; Mihael Vucur; Henning Zimmermann; Sabine Schmidt; Jörn Janssen; Christiane Koppe; Percy Knolle; Mirco Castoldi; Frank Tacke; Christian Trautwein; Tom Luedde
Journal:  Hepatology       Date:  2010-10-01       Impact factor: 17.425

3.  miR-192 mediates TGF-beta/Smad3-driven renal fibrosis.

Authors:  Arthur C K Chung; Xiao R Huang; Xiaoming Meng; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2010-05-20       Impact factor: 10.121

4.  MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.

Authors:  Jianyin Long; Yin Wang; Wenjian Wang; Benny H J Chang; Farhad R Danesh
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

5.  The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy.

Authors:  Olga Zhdanova; Shekhar Srivastava; Lie Di; Zhai Li; Leila Tchelebi; Sara Dworkin; Duncan B Johnstone; Jiri Zavadil; Mark M Chong; Dan R Littman; Lawrence B Holzman; Laura Barisoni; Edward Y Skolnik
Journal:  Kidney Int       Date:  2011-05-04       Impact factor: 10.612

6.  Epigenetics in diabetic kidney disease.

Authors:  Marpadga A Reddy; Rama Natarajan
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

7.  TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.

Authors:  Wei Qin; Arthur C K Chung; Xiao R Huang; Xiao-Ming Meng; David S C Hui; Cheuk-Man Yu; Joseph J Y Sung; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

8.  Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis.

Authors:  Bo Wang; Radko Komers; Rosemarie Carew; Catherine E Winbanks; Bei Xu; Michal Herman-Edelstein; Philip Koh; Merlin Thomas; Karin Jandeleit-Dahm; Paul Gregorevic; Mark E Cooper; Phillip Kantharidis
Journal:  J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 10.121

9.  Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury.

Authors:  Jacqueline Ho; Kar Hui Ng; Seymour Rosen; Ales Dostal; Richard I Gregory; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2008-10-02       Impact factor: 10.121

10.  TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN.

Authors:  Mitsuo Kato; Sumanth Putta; Mei Wang; Hang Yuan; Linda Lanting; Indu Nair; Amanda Gunn; Yoshimi Nakagawa; Hitoshi Shimano; Ivan Todorov; John J Rossi; Rama Natarajan
Journal:  Nat Cell Biol       Date:  2009-06-21       Impact factor: 28.824
View more
  1 in total

1.  TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion.

Authors:  Nirmalya Dey; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.